During a visit by Indian President to Sweden between 31 May – 2 June 2015, a MoI was signed between India’s Central Drugs Standard Control Organization (CDSCO) and the Swedish Medical Products Agency (MPA). This agreement, complimentary to the ongoing cooperation between India and Sweden covering the area of health, is for increasing bilateral cooperation in the fields of pharmacovigilance, electronic submissions in related matter, clinical trials, drugs, medical devices and diagnostic kits, cosmetic and hygiene products and for exchange of information and experiences regarding good manufacturing practice, said the statement.